Table 3. Factors affected treatment outcomes: univariable analysis.
| Factors | OS | PFS | |||
|---|---|---|---|---|---|
| HR (95% CI) | p-value | HR (95% CI) | p-value | ||
| Pathological results | |||||
| SCC vs. ADC | 0.92 (0.57–1.50) | 0.747 | 0.94 (0.58–1.54) | 0.816 | |
| Treatment modality | |||||
| RT vs. CCRT | 0.91 (0.64–1.29) | 0.595 | 0.98 (0.69–1.38) | 0.889 | |
| Pretreatment anemia | |||||
| No vs. yes | 1.33 (0.88–1.99) | 0.177 | 1.32 (0.89–1.99) | 0.181 | |
| TTT (day) | |||||
| ≤56 vs. >56 | 1.40 (0.98–1.98) | 0.062 | 1.44 (1.01–2.04) | 0.041 | |
| LTI | |||||
| No vs. yes | 1.69 (1.19–2.42) | 0.003 | 1.72 (1.21–2.46) | 0.002 | |
ADC, adenocarcinoma; CCRT, concurrent chemoradiation therapy; CI, confidence interval; HR, hazard ratio; LTI, lower third of vaginal invasion; OS, overall survival; PFS, progression-free survival; RT, radiation therapy; SCC, squamous cell carcinoma; TTT, total treatment time.